AQUABOUNTY TECHNOLOGIES INCAQBEarnings & Financial Report
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024.
AQB Q2 FY2024 Key Financial Metrics
Revenue
$180.2K
Gross Profit
N/A
Operating Profit
$-29.6M
Net Profit
$-50.5M
Gross Margin
N/A
Operating Margin
-16405.6%
Net Margin
-28035.1%
YoY Growth
-77.1%
EPS
$-13.08
AQUABOUNTY TECHNOLOGIES INC Q2 FY2024 Financial Summary
AQUABOUNTY TECHNOLOGIES INC reported revenue of $180.2K (down 77.1% YoY) for Q2 FY2024, with a net profit of $-50.5M (down 676.1% YoY) (-28035.1% margin).
Key Financial Metrics
| Total Revenue | $180.2K |
|---|---|
| Net Profit | $-50.5M |
| Gross Margin | N/A |
| Operating Margin | -16405.6% |
| Report Period | Q2 FY2024 |
AQUABOUNTY TECHNOLOGIES INC Annual Revenue by Year
AQUABOUNTY TECHNOLOGIES INC annual revenue history includes year-by-year totals (for example, 2023 revenue was $2.5M).
AQUABOUNTY TECHNOLOGIES INC Quarterly Revenue & Net Profit History
AQUABOUNTY TECHNOLOGIES INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2024 | $180.2K | -77.1% | $-50.5M | -28035.1% |
| Q1 FY2024 | $477.3K | +20.0% | $-11.2M | -2337.9% |
| Q4 FY2023 | $553.3K | +22.7% | N/A | N/A |
| Q3 FY2023 | $733.1K | +12.2% | $-6.1M | -837.2% |
| Q2 FY2023 | $788.4K | -26.3% | $-6.5M | -825.5% |
| Q1 FY2023 | $397.8K | -58.7% | $-6.5M | -1630.3% |
| Q4 FY2022 | $450.9K | +8.0% | $-6.1M | -1345.9% |
| Q3 FY2022 | $653.4K | +43.5% | $-5.4M | -832.5% |
Income Statement
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $653432 | $450935 | $397846 | $788430 | $733133 | $553250 | $477268 | $180182 |
| YoY Growth | 43.5% | 8.0% | -58.7% | -26.3% | 12.2% | 22.7% | 20.0% | -77.1% |
Balance Sheet
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $222.7M | $213.8M | $206.3M | $210.2M | $192.5M | $187.6M | $176.2M | $127.4M |
| Liabilities | $24.9M | $21.9M | $20.7M | $30.9M | $19.4M | $22.5M | $22.3M | $24.1M |
| Equity | $197.8M | $191.9M | $185.6M | $179.3M | $173.2M | $165.0M | $153.8M | $103.3M |
Cash Flow
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-6.7M | $-3.1M | $-6.1M | $-6.1M | $-6.2M | $-5.8M | $-4.4M | $-4.3M |